Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 1250.00 | 894.42 | 915.00 | 1926.00 | 0.4751 | 0.0208 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1976.00 | 1926.00 | 1.0260 | 1.0469 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1808.00 | 1926.00 | 0.9387 | 0.8889 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4234.00 | 4227.00 | 1.0017 | 1.0030 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4165.00 | 4227.00 | 0.9853 | 0.9736 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4419.00 | 4227.00 | 1.0454 | 1.0815 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4565.00 | 4227.00 | 1.0800 | 1.1432 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 2500.00 | 1955.17 | 4165.00 | 4227.00 | 0.9853 | 0.9736 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 2500.00 | 1955.17 | 4266.00 | 4227.00 | 1.0092 | 1.0166 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 3360.00 | 4227.00 | 0.7949 | 0.6271 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 2500.00 | 1955.17 | 2134.00 | 4227.00 | 0.5049 | 0.0819 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 2818.00 | 4227.00 | 0.6667 | 0.3891 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 2500.00 | 1955.17 | 4446.00 | 4227.00 | 1.0518 | 1.0929 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4439.00 | 4227.00 | 1.0502 | 1.0900 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 2500.00 | 1955.17 | 1879.00 | 4227.00 | 0.4445 | -0.0351 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 4502.00 | 4227.00 | 1.0651 | 1.1166 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 2265.00 | 4227.00 | 0.5358 | 0.1414 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 4391.00 | 4227.00 | 1.0388 | 1.0696 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 3663.00 | 4227.00 | 0.8666 | 0.7584 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 4205.00 | 4227.00 | 0.9948 | 0.9906 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 4199.00 | 4227.00 | 0.9934 | 0.9881 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 2500.00 | 1955.17 | 4397.00 | 4227.00 | 1.0402 | 1.0722 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 2500.00 | 1955.17 | 4383.00 | 4227.00 | 1.0369 | 1.0662 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 2421.00 | 4227.00 | 0.5728 | 0.2118 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 1960.00 | 4227.00 | 0.4637 | 0.0022 |